Document Detail

A comparison of patient characteristics and 30-day mortality outcomes after transcatheter aortic valve implantation and surgical aortic valve replacement for the treatment of aortic stenosis: a two-centre study.
MedLine Citation:
PMID:  20142179     Owner:  NLM     Status:  MEDLINE    
AIMS: It is unclear whether transcatheter aortic valve implantation (TAVI) addresses an unmet clinical need for those currently rejected for surgical aortic valve replacement (SAVR) and whether there is a subgroup of high-risk patients benefiting more from TAVI compared to SAVR. In this two-centre, prospective cohort study, we compared baseline characteristics and 30-day mortality between TAVI and SAVR in consecutive patients undergoing invasive treatment for aortic stenosis. METHODS AND RESULTS: We pre-specified different adjustment methods to examine the effect of TAVI as compared with SAVR on overall 30-day mortality: crude univariable logistic regression analysis, multivariable analysis adjusted for baseline characteristics, analysis adjusted for propensity scores, propensity score matched analysis, and weighted analysis using the inverse probability of treatment (IPT) as weights. A total of 1,122 patients were included in the study: 114 undergoing TAVI and 1,008 patients undergoing SAVR. The crude mortality rate was greater in the TAVI group (9.6% vs. 2.3%) yielding an odds ratio [OR] of 4.57 (95%-CI 2.17-9.65). Compared to patients undergoing SAVR, patients with TAVI were older, more likely to be in NYHA class III and IV, and had a considerably higher logistic EuroSCORE and more comorbid conditions. Adjusted OR depended on the method used to control for confounding and ranged from 0.60 (0.11-3.36) to 7.57 (0.91-63.0). We examined the distribution of propensity scores and found scores to overlap sufficiently only in a narrow range. In patients with sufficient overlap of propensity scores, adjusted OR ranged from 0.35 (0.04-2.72) to 3.17 (0.31 to 31.9). In patients with insufficient overlap, we consistently found increased odds of death associated with TAVI compared with SAVR irrespective of the method used to control confounding, with adjusted OR ranging from 5.88 (0.67-51.8) to 25.7 (0.88-750). Approximately one third of patients undergoing TAVI were found to be potentially eligible for a randomised comparison of TAVI versus SAVR. CONCLUSIONS: Both measured and unmeasured confounding limit the conclusions that can be drawn from observational comparisons of TAVI versus SAVR. Our study indicates that TAVI could be associated with either substantial benefits or harms. Randomised comparisons of TAVI versus SAVR are warranted.
Nicolo Piazza; Menno van Gameren; Peter Jüni; Peter Wenaweser; Thierry Carrel; Yoshinobu Onuma; Brigitta Gahl; Gerrit Hellige; Amber Otten; Arie-Pieter Kappetein; Johanna J M Takkenberg; Ron van Domburg; Peter de Jaegere; Patrick W Serruys; Stephan Windecker
Related Documents :
8011409 - Aortic valve replacement in elderly patients with aortic stenosis.
20959999 - First experience with transcatheter aortic valve implantation and concomitant percutane...
7629209 - Valvular replacement for aortic stenosis on patients in nyha class iii and iv. early an...
1929609 - Chronic visceral ischemia. three decades of progress.
19557979 - Risk of reoperation for aortic bioprosthesis dysfunction.
1607519 - Intermediate-term outcome after pulmonary balloon valvuloplasty: comparison with a matc...
20677989 - Comparative analysis of outcome between open and robotic surgical repair of recurrent s...
22924309 - Radical retropubic prostatectomy--experience of two urological departments.
25468319 - Oncologic results of nephron sparing endoscopic approach for upper tract low grade tran...
Publication Detail:
Type:  Comparative Study; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology     Volume:  5     ISSN:  1969-6213     ISO Abbreviation:  EuroIntervention     Publication Date:  2009 Nov 
Date Detail:
Created Date:  2010-02-09     Completed Date:  2010-08-12     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101251040     Medline TA:  EuroIntervention     Country:  France    
Other Details:
Languages:  eng     Pagination:  580-8     Citation Subset:  IM    
Department of Interventional Cardiology, Thoraxcenter, Erasmus Medical Center, Rotterdam, The Netherlands.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Aged, 80 and over
Aortic Valve Stenosis / mortality*,  surgery,  therapy*
Chi-Square Distribution
Confounding Factors (Epidemiology)
Heart Catheterization / adverse effects,  mortality*
Heart Valve Prosthesis Implantation / adverse effects,  mortality*
Logistic Models
Middle Aged
Odds Ratio
Patient Selection
Propensity Score
Prospective Studies
Risk Assessment
Risk Factors
Time Factors
Treatment Outcome

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Determination of haemodynamic significance of intermediate coronary lesions using three-dimensional ...
Next Document:  Safety, efficacy and long-term durability of endovascular therapy for carotid artery disease: the ta...